There is a newer version of the record available.

Published August 28, 2017 | Version v1

SGC-GAK-1: A chemical probe candidate for the understudied kinase GAK

Description

SGC-GAK-1 is presented as a chemical probe for the understudied cyclin G associated kinase (GAK). SGC-GAK-1 is potent and shows submicromolar cellular target engagement with GAK. The compound shows > 30-fold selectivity relative to all other kinases profiled with the exception of RIPK2. A closely related molecule that is significantly less potent with GAK, SGC-GAK-1N, is included as a negative control. In addition, a compound having potent activity at RIPK2 but not GAK, HY-19764, is offered to control for the activity of RIPK2. 

Notes

The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust.

Files

Files (3.8 MB)

Name Size Download all
md5:1a71d245f493ddd0f22f45570d4f512c
3.8 MB Download